Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Endocr Relat Cancer. 2016 Jul 18;23(9):739–746. doi: 10.1530/ERC-16-0246

Figure 2.

Figure 2

Kaplan-Meier Curve of penetrance (time to first myxoma) grouped by presence or absence of growth hormone (GH) excess, restricted to those age 21 or older at the time of GH testing. Those with GH excess had a median time to first myxoma of 34.5 years (95% CI: 28.7–46.2) compared to 45.2 years [95% CI: 33.4-(undefined upper bound)] in those without GH excess (p =0.0709).